5.44 - 5.64
4.95 - 8.28
2.1K / 2.4K (Avg.)
-272.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.12%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
202.67%
Gross profit growth above 1.5x VALMT.HE's 6.12%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
269.03%
Positive EBIT growth while VALMT.HE is negative. John Neff might see a substantial edge in operational management.
269.03%
Positive operating income growth while VALMT.HE is negative. John Neff might view this as a competitive edge in operations.
418.89%
Net income growth above 1.5x VALMT.HE's 17.24%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
414.96%
EPS growth above 1.5x VALMT.HE's 19.35%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
414.96%
Diluted EPS growth above 1.5x VALMT.HE's 19.35%. David Dodd would see if there's a robust moat protecting these shareholder gains.
1.11%
Slight or no buybacks while VALMT.HE is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
1.11%
Slight or no buyback while VALMT.HE is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
153.49%
Positive OCF growth while VALMT.HE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-74.15%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-3.36%
Negative 10Y revenue/share CAGR while VALMT.HE stands at 73.72%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
1.08%
5Y revenue/share CAGR under 50% of VALMT.HE's 23.33%. Michael Burry would suspect a significant competitive gap or product weakness.
-4.19%
Negative 3Y CAGR while VALMT.HE stands at 12.65%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-91.08%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-89.59%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-92.29%
Negative 3Y OCF/share CAGR while VALMT.HE stands at 55.53%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
37.31%
Below 50% of VALMT.HE's 236.36%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-12.49%
Negative 5Y net income/share CAGR while VALMT.HE is 8.82%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-64.04%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
108.37%
10Y equity/share CAGR at 50-75% of VALMT.HE's 145.38%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
36.57%
Below 50% of VALMT.HE's 119.69%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
7.77%
Below 50% of VALMT.HE's 65.95%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
3.40%
We show growth while VALMT.HE is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
2.00%
Positive asset growth while VALMT.HE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
1.73%
Similar to VALMT.HE's 1.77%. Walter Schloss finds parallel capital usage or profit distribution strategies.
-80.84%
We’re deleveraging while VALMT.HE stands at 0.63%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
We cut SG&A while VALMT.HE invests at 23.98%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.